Amarin Corp PLC (AMRN)
0.5217
-0.03
(-4.90%)
USD |
NASDAQ |
Nov 25, 14:16
Amarin Revenue (Quarterly): 42.30M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 42.30M |
| June 30, 2024 | 67.49M |
| March 31, 2024 | 56.52M |
| December 31, 2023 | 74.71M |
| September 30, 2023 | 66.06M |
| June 30, 2023 | 80.17M |
| March 31, 2023 | 85.98M |
| December 31, 2022 | 90.24M |
| September 30, 2022 | 89.88M |
| June 30, 2022 | 94.44M |
| March 31, 2022 | 94.63M |
| December 31, 2021 | 144.49M |
| September 30, 2021 | 142.04M |
| June 30, 2021 | 154.49M |
| March 31, 2021 | 142.17M |
| December 31, 2020 | 167.25M |
| September 30, 2020 | 156.50M |
| June 30, 2020 | 135.32M |
| March 31, 2020 | 154.99M |
| December 31, 2019 | 143.28M |
| September 30, 2019 | 112.41M |
| June 30, 2019 | 100.79M |
| March 31, 2019 | 73.28M |
| December 31, 2018 | 77.33M |
| September 30, 2018 | 55.32M |
| Date | Value |
|---|---|
| June 30, 2018 | 52.64M |
| March 31, 2018 | 43.92M |
| December 31, 2017 | 53.87M |
| September 30, 2017 | 47.36M |
| June 30, 2017 | 45.24M |
| March 31, 2017 | 34.64M |
| December 31, 2016 | 38.70M |
| September 30, 2016 | 32.73M |
| June 30, 2016 | 33.11M |
| March 31, 2016 | 25.54M |
| December 31, 2015 | 26.63M |
| September 30, 2015 | 21.48M |
| June 30, 2015 | 17.71M |
| March 31, 2015 | 15.93M |
| December 31, 2014 | 16.48M |
| September 30, 2014 | 14.15M |
| June 30, 2014 | 12.61M |
| March 31, 2014 | 10.97M |
| December 31, 2013 | 10.11M |
| September 30, 2013 | 8.403M |
| June 30, 2013 | 5.50M |
| March 31, 2013 | 2.341M |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
42.30M
Minimum
Sep 2024
167.25M
Maximum
Dec 2020
109.15M
Average
94.54M
Median
Revenue (Quarterly) Benchmarks
| Trinity Biotech PLC | 15.15M |
| Edap TMS SA | 14.41M |
| Adaptimmune Therapeutics PLC | 40.90M |
| Akari Therapeutics PLC | -- |
| NuCana PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.13M |
| Total Expenses (Quarterly) | 67.47M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | -80.07M |
| Gross Profit Margin (Quarterly) | 38.48% |
| Profit Margin (Quarterly) | -59.42% |
| Earnings Yield | -18.46% |
| Normalized Earnings Yield | -18.37 |